Form 8-K - Current report:
SEC Accession No. 0001698530-25-000102
Filing Date
2025-11-10
Accepted
2025-11-10 16:17:16
Documents
12
Period of Report
2025-11-06
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K xcur-20251106.htm   iXBRL 8-K 35679
  Complete submission text file 0001698530-25-000102.txt   150792

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20251106.xsd EX-101.SCH 1788
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20251106_lab.xml EX-101.LAB 21629
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20251106_pre.xml EX-101.PRE 12512
14 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20251106_htm.xml XML 2720
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1707
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39011 | Film No.: 251466467
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)